Literature DB >> 26011290

Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.

Shanna Litau1,2, Uwe Seibold1,2, Alicia Vall-Sagarra1, Gert Fricker3, Björn Wängler2, Carmen Wängler4.   

Abstract

For (64) Cu radiolabeling of biomolecules to be used as in vivo positron emission tomography (PET) imaging agents, various chelators are commonly applied. It has not yet been determined which of the most potent chelators--NODA-GA ((1,4,7-triazacyclononane-4,7-diyl)diacetic acid-1-glutaric acid), CB-TE2A (2,2'-(1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-4,11-diyl)diacetic acid), or CB-TE1A-GA (1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-4,11-diyl-8-acetic acid-1-glutaric acid)--forms the most stable complexes resulting in PET images of highest quality. We determined the (64) Cu complex stabilities for these three chelators by a combination of complex challenge and an in vivo approach. For this purpose, bioconjugates of the chelating agents with the gastrin-releasing peptide receptor (GRPR)-affine peptide PESIN and an integrin αv β3 -affine c(RGDfC) tetramer were synthesized and radiolabeled with (64) Cu in excellent yields and specific activities. The (64) Cu-labeled biomolecules were evaluated for their complex stabilities in vitro by conducting a challenge experiment with the respective other chelators as challengers. The in vivo stabilities of the complexes were also determined, showing the highest stability for the (64) Cu-CB-TE1A-GA complex in both experimental setups. Therefore, CB-TE1A-GA is the most appropriate chelating agent for *Cu-labeled radiotracers and in vivo imaging applications.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  complex stability; copper-64; in vivo imaging; positron emission tomography; radiochemistry

Mesh:

Substances:

Year:  2015        PMID: 26011290     DOI: 10.1002/cmdc.201500132

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  8 in total

1.  Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.

Authors:  Marianna Tosato; Marco Verona; Chiara Favaretto; Marco Pometti; Giordano Zanoni; Fabrizio Scopelliti; Francesco Paolo Cammarata; Luca Morselli; Zeynep Talip; Nicholas P van der Meulen; Valerio Di Marco; Mattia Asti
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

2.  Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs.

Authors:  Huaifu Deng; Hui Wang; He Zhang; Mengzhe Wang; Ben Giglio; Xiaofen Ma; Guihua Jiang; Hong Yuan; Zhanhong Wu; Zibo Li
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

3.  iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings.

Authors:  Shanna Litau; Uwe Seibold; Björn Wängler; Ralf Schirrmacher; Carmen Wängler
Journal:  ACS Omega       Date:  2018-10-25

4.  Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye.

Authors:  Ralph Hübner; Valeska von Kiedrowski; Vanessa Benkert; Björn Wängler; Ralf Schirrmacher; Roland Krämer; Carmen Wängler
Journal:  Pharmaceuticals (Basel)       Date:  2020-09-16

5.  Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors.

Authors:  Benedikt Judmann; Diana Braun; Ralf Schirrmacher; Björn Wängler; Gert Fricker; Carmen Wängler
Journal:  ACS Omega       Date:  2022-07-28

6.  PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study.

Authors:  Ralph Hübner; Alexa Paretzki; Valeska von Kiedrowski; Marco Maspero; Xia Cheng; Güllü Davarci; Diana Braun; Helen Damerow; Benedikt Judmann; Vasileios Filippou; Clelia Dallanoce; Ralf Schirrmacher; Björn Wängler; Carmen Wängler
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-02

7.  Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer.

Authors:  Isabel Hinsenkamp; Sandra Schulz; Mareike Roscher; Anne-Maria Suhr; Björn Meyer; Bogdan Munteanu; Jens Fuchser; Stefan O Schoenberg; Matthias P A Ebert; Björn Wängler; Carsten Hopf; Elke Burgermeister
Journal:  Neoplasia       Date:  2016-08       Impact factor: 5.715

8.  Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability.

Authors:  Helen Damerow; Ralph Hübner; Benedikt Judmann; Ralf Schirrmacher; Björn Wängler; Gert Fricker; Carmen Wängler
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.